The abnormal expression of TYROBP has been reported to take part in numerous diseases, such as Alzheimer’s disease, breast cancer, osteosarcoma and renal cell carcinoma. This evidence concerns the gene TYROBP and early-onset autosomal dominant Alzheimer disease.